Fingerprint
Dive into the research topics of 'Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
Nathan W.D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Younis
Research output: Contribution to journal › Article › peer-review
54
Citations
(Scopus)